Journals
Publish with us
Publishing partnerships
About us
Blog
Disease Markers
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Disease Markers
/
2021
/
Article
/
Tab 2
/
Research Article
Ethacrynic Acid Enhances the Antitumor Effects of Afatinib in EGFR/T790M-Mutated NSCLC by Inhibiting WNT/Beta-Catenin Pathway Activation
Table 2
The antitumor effects of EA combined with afatinib
in vivo
(
).
Group
A549
H1975
Tumor weight (mg)
Inhibition rate (%)
Tumor weight (mg)
Inhibition rate (%)
Control
0
0
Afatinib
EA
Afatinib+EA
value
18.345
50.192
value
0.000
0.000